|Number of pages||3|
|Journal||JAMA - Journal of the American Medical Association|
|Publication status||Published - 2019 Dec 24|
Bibliographical noteFunding Information:
Conflict of Interest Disclosures: Dr Mannstadt reported receipt of grants and personal fees from Shire. Dr S. Lee reported receipt of grants from Takeda Science Foundation. No other disclosures were reported.
Funding/Support: This study was supported by the Basic Science Research Program of the National Research Foundation of Korea (grant NRF-2019R1F1A1063459 to Dr S. Lee) and in part by the Ewha Womans University Research Grant of 2018 (to Dr Ahn).
1. Ahn HS, Kim HJ, Welch HG. Korea’s thyroid-cancer “epidemic”—screening and overdiagnosis. N Engl J Med. 2014;371(19):1765-1767. doi:10.1056/NEJMp1409841 2. Korea Central Cancer Registry, National Cancer Center, Ministry of Health and Welfare. Annual Report of Cancer Statistics in Korea in 2016. https://ncc.re.kr/ main.ncc?uri=english/sub04_Statistics. Published December 2018. Accessed October 31, 2019.
Author Affiliations: Icahn School of Medicine at Mount Sinai, New York, New York (Powers); Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York (Marcadis, Morris); Department of Surgery, Weill Cornell Medicine, New York, New York (Lee, Marti). Accepted for Publication: October 22, 2019. CorrespondingAuthor:JenniferL.Marti,MD,DepartmentofSurgery,WeillCornell Medicine, 420 E 70th St, New York, NY 10065 (email@example.com). Author Contributions: Drs Morris and Marti, who jointly supervised the work and share senior authorship, had full access to the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: All authors. Acquisition, analysis, or interpretation of data: Powers, Marcadis, Lee, Morris. Drafting of the manuscript: Powers, Marcadis, Lee, Morris. Critical revision of the manuscript for important intellectual content: All authors. Statistical analysis: Powers, Marcadis, Lee, Morris. Administrative, technical, or material support: Marcadis, Morris. Supervision: Morris, Marti. Conflict of Interest Disclosures: Dr Morris reported receipt of personal fees from Rakuten Aspyrian; in addition, the Morris laboratory receives research funding from Illumina Inc and AstraZeneca for laboratory research. No other disclosures were reported. Additional Contributions: We acknowledge Jill Gregory, CMI, and Ni-ka Ford, MS, Icahn School of Medicine at Mount Sinai, for their uncompensated assistance with the Figure. 1. Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in thyroid cancer incidence and mortality in the United States, 1974-2013. JAMA. 2017;317(13): 1338-1348. doi:10.1001/jama.2017.2719 2. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295(18):2164-2167. doi:10.1001/jama.295.18.2164 3. Furuya-Kanamori L, Bell KJL, Clark J, Glasziou P, Doi SAR. Prevalence of differentiated thyroid cancer in autopsy studies over six decades: a meta-analysis. J Clin Oncol. 2016;34(30):3672-3679. doi:10.1200/JCO.2016.67.7419 4. Ahn HS, Welch HG. South Korea’s thyroid-cancer “epidemic”—turning the tide. N Engl J Med. 2015;373(24):2389-2390. doi:10.1056/NEJMc1507622 5. Bibbins-DomingoK,GrossmanDC,CurrySJ,etal;USPreventiveServicesTaskForce. Screening for thyroid cancer: US Preventive Services Task Force recommendation statement. JAMA. 2017;317(18):1882-1887. doi:10.1001/jama.2017.4011 6. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26 (1):1-133. doi:10.1089/thy.2015.0020
All Science Journal Classification (ASJC) codes